Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy

被引：0
|
作者：
Kaur, PP [1 ]
Derk, CT [1 ]
Chatterji, M [1 ]
Dehoratius, RJ [1 ]
机构：
[1] Thomas Jefferson Univ, Div Rheumatol, Dept Med, Philadelphia, PA 19107 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2004年 / 31卷 / 08期
关键词：
septic arthritis; Actinobacillus ureae; rheumatoid arthritis; tumor necrosis alpha inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Actinobacillus ureae, formerly known as Pasteurella ureae, is a rare human pathogen. We describe a case of septic arthritis and abscess formation caused by this unusual organism in a patient with rheumatoid arthritis, who was being treated with tumor necrosis factor-cc inhibitors.
引用
收藏
页码：1663 / 1665
页数：3
相关论文
共 50 条
  • [41] Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
    Catrina, AI
    af Klint, E
    Ernestam, S
    Catrina, SB
    Makrygiannakis, D
    Botusan, IR
    Klareskog, L
    Ulfgren, AK
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 76 - 81
  • [42] Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
    Bao-Anh Nguyen-Khoa
    Goehring, Earl L., Jr.
    Alexander, Kimberly A.
    Dong, Wei
    Napalkov, Pavel
    Jones, Judith K.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (02) : 119 - 126
  • [43] Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-α treatment
    Bassetti, S
    Wasmer, S
    Hasler, P
    Vogt, T
    Nogarth, D
    Frei, R
    Widmer, AF
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2125 - 2129
  • [44] Anti-tumor necrosis factor α therapy in psoriatic arthritis and psoriasis
    Girolomoni, G
    Abeni, D
    [J]. ARCHIVES OF DERMATOLOGY, 2001, 137 (06) : 784 - 785
  • [45] Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis
    Ziolkowska, M
    Maslinski, W
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 267 - 273
  • [46] Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor?
    Altschuler, EL
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 2000, 22 (11): : 1007 - 1008
  • [47] Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-α therapy in patients with rheumatoid arthritis
    Braun-Moscovici, Y
    Markovits, D
    Zinder, O
    Schapira, D
    Rozin, A
    Ehrenburg, M
    Dain, L
    Hoffer, E
    Nahir, AM
    Balbir-Gurman, A
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (03) : 497 - 500
  • [48] Treatment of recalcitrant psoriatic arthritis with anti-tumor necrosis factor-α antibody
    Wollina, U
    Konrad, H
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2002, 16 (02) : 127 - 129
  • [49] Erratum to: Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Gianluigi Mazzoccoli
    Incoronata Notarsanto
    Gennaro Davide de Pinto
    Mariangela Pia Dagostino
    Angelo De Cata
    Giuseppe D’Alessandro
    Roberto Tarquini
    Gianluigi Vendemiale
    [J]. Internal and Emergency Medicine, 2011, 6 : 97 - 97
  • [50] Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor
    Zamarrón, C
    Maceiras, F
    González, J
    Gómez-Reino, JJ
    [J]. RESPIRATORY MEDICINE, 2004, 98 (02) : 123 - 125
12345